Bausch Health Cos Operating Income 2010-2024 | BHC
Bausch Health Cos operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Bausch Health Cos Annual Operating Income (Millions of US $) |
2023 |
$963 |
2022 |
$454 |
2021 |
$450 |
2020 |
$676 |
2019 |
$-203 |
2018 |
$-2,384 |
2017 |
$102 |
2016 |
$-566 |
2015 |
$1,527 |
2014 |
$2,001 |
2013 |
$-410 |
2012 |
$80 |
2011 |
$300 |
2010 |
$-110 |
2009 |
$181 |
Bausch Health Cos Quarterly Operating Income (Millions of US $) |
2024-09-30 |
$318 |
2024-06-30 |
$389 |
2024-03-31 |
$281 |
2023-12-31 |
$362 |
2023-09-30 |
$14 |
2023-06-30 |
$412 |
2023-03-31 |
$175 |
2022-12-31 |
$-244 |
2022-09-30 |
$244 |
2022-06-30 |
$161 |
2022-03-31 |
$293 |
2021-12-31 |
$367 |
2021-09-30 |
$574 |
2021-06-30 |
$-270 |
2021-03-31 |
$-221 |
2020-12-31 |
$-5 |
2020-09-30 |
$460 |
2020-06-30 |
$-27 |
2020-03-31 |
$248 |
2019-12-31 |
$-1,076 |
2019-09-30 |
$329 |
2019-06-30 |
$257 |
2019-03-31 |
$287 |
2018-12-31 |
$25 |
2018-09-30 |
$117 |
2018-06-30 |
$-245 |
2018-03-31 |
$-2,281 |
2017-12-31 |
$-322 |
2017-09-30 |
$38 |
2017-06-30 |
$175 |
2017-03-31 |
$211 |
2016-12-31 |
$150 |
2016-09-30 |
$-863 |
2016-06-30 |
$81 |
2016-03-31 |
$66 |
2015-12-31 |
$167 |
2015-09-30 |
$448 |
2015-06-30 |
$342 |
2015-03-31 |
$571 |
2014-12-31 |
$605 |
2014-09-30 |
$684 |
2014-06-30 |
$355 |
2014-03-31 |
$357 |
2013-12-31 |
$224 |
2013-09-30 |
$-892 |
2013-06-30 |
$142 |
2013-03-31 |
$117 |
2012-12-31 |
$-98 |
2012-09-30 |
$29 |
2012-06-30 |
$87 |
2012-03-31 |
$61 |
2011-12-31 |
$-6 |
2011-09-30 |
$112 |
2011-06-30 |
$118 |
2011-03-31 |
$75 |
2010-12-31 |
$-49 |
2010-09-30 |
$-126 |
2010-06-30 |
$49 |
2010-03-31 |
$16 |
2009-12-31 |
$59 |
2009-09-30 |
$58 |
2009-06-30 |
$11 |
2009-03-31 |
$54 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$2.931B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|